Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Pledpharma: The clinical hold could be temporary

2020-01-24

07:27

KP

Klas Palin

We don't want to downplay the importance of the FDA's decision to place PledOx on clinical hold in the US, however, as long as the DSMB continues to recommend a continuation of the POLAR program, we believe the decision could be of a temporary nature. We continue to be positive about the current valuation of Pledpharma. Still, we expect the share price to remain under pressure until we get further clarity from the FDA (likely to happen in the next 1-3 months).

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers